title: Innovations in chemotherapy and radiation therapy: Implications and opportunities for the Asia-Pacific Rim.
abstract: New cases of invasive cancer in the United States occur among nearly 1.5 million people annually. In 2007, more than 1,500 people died per day with this diagnosis. Cancer is responsible for nearly one in every four deaths reported in the country. Enormous amounts of money and research have been, and are being spent, in an attempt to improve these numbers. While prevention and early detection remain the key to long-term success, treatment in the neo-adjuvant, adjuvant and metastatic settings still centre around two main treatment modalities - radiation therapy and chemotherapy. This article will review the advances that have been made in both areas that are making these treatments more precise and convenient, as well as less toxic, for the patient. In the field of radiation therapy this involves the development of new therapy planning and delivery systems, such as intensity-modulated radiation therapy (IMRT), and positron emission and computed tomography, PET-CT. Chemotherapy has also evolved with the development of targeted chemotherapy for the treatment of specific malignancies as well as improved supportive care agents which allow for the administration of dose-dense chemotherapy when appropriate.
authors: D E
authors: DE
authors: Heron
authors: J E
authors: JE
authors: Shogan
authors: J W
authors: JW
authors: Mucenski
references: Semin Radiat Oncol. 2002 Jul;12(3):260-71
references: 12118391
references: Radiother Oncol. 1997 Jan;42(1):87-90
references: 9132831
references: Cancer. 2007 Jun 1;109(11):2171-81
references: 17431887
references: Clin Cancer Res. 2008 Mar 1;14(5):1296-302
references: 18316547
references: Drug News Perspect. 2008 Mar;21(2):123-4
references: 18389103
references: J Clin Oncol. 2003 Nov 1;21(21):4042-57
references: 12963702
references: Breast Cancer Res Treat. 2007 Sep;105(1):17-28
references: 17111207
references: N Engl J Med. 2004 Dec 30;351(27):2817-26
references: 15591335
references: Int J Radiat Oncol Biol Phys. 1988 Aug;15(2):481-95
references: 3403328
references: Expert Opin Investig Drugs. 2008 Jun;17(6):879-95
references: 18491989
references: Int J Radiat Oncol Biol Phys. 1996 Aug 1;36(1):167-74
references: 8823272
references: Expert Opin Investig Drugs. 2008 Mar;17(3):371-85
references: 18321236
references: Oncology (Williston Park). 2008 Apr 15;22(4):408-16; discussion 416, 421, 424 passim
references: 18472615
references: Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):505-12
references: 15380585
references: J Clin Oncol. 2006 Jul 1;24(19):3187-205
references: 16682719
references: Oncogene. 2007 May 28;26(25):3637-43
references: 17530017
references: Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):380-6
references: 18296593
references: World J Gastroenterol. 2007 Nov 28;13(44):5877-87
references: 17990353
references: Radiother Oncol. 1994 Feb;30(2):150-4
references: 8184113
references: Am J Roentgenol Radium Ther Nucl Med. 1959 Jan;81(1):4-12
references: 13606273
references: Curr Probl Cancer. 2003 Jan-Feb;27(1):60-3
references: 12569353
references: J Clin Oncol. 2007 Aug 10;25(23):3525-33
references: 17687157
references: Gynecol Oncol. 2003 Oct;91(1):39-45
references: 14529660
references: Oncologist. 2007 Dec;12(12):1404-15
references: 18165617
references: Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):1051-7
references: 12095574
references: Gynecol Oncol. 2001 Sep;82(3):456-63
references: 11520140
references: Expert Opin Investig Drugs. 2007 Nov;16(11):1799-815
references: 17970639
references: J Clin Oncol. 2008 Jul 10;26(20):3317-23
references: 18490651
references: Int J Radiat Oncol Biol Phys. 2003 Feb 1;55(2):362-72
references: 12527049
references: J Clin Oncol. 2008 Aug 1;26(22):3777-84
references: 18669466
references: Ann Oncol. 2007 Jun;18 Suppl 6:vi26-30
references: 17591827
references: Semin Radiat Oncol. 2002 Jul;12(3):229-37
references: 12118388
references: Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1395-400
references: 16442238
references: J Clin Oncol. 2005 Apr 10;23(11):2534-43
references: 15699478
references: Arthritis Res Ther. 2007;9 Suppl 1:S7
references: 17634146
references: Radiother Oncol. 1995 Jun;35(3):240-7
references: 7480828
references: Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):189-96
references: 15978745
references: Ann Surg Oncol. 2006 Oct;13(10):1296-321
references: 16990987
references: Annu Rev Med. 2008;59:237-50
references: 18186705
references: Curr Treat Options Oncol. 2007 Aug;8(4):265-76
references: 18097642
references: Eur J Cancer. 2007 Mar;43(5):852-8
references: 17258449
references: Semin Radiat Oncol. 1999 Jan;9(1):1-3
references: 10196394
references: J Clin Oncol. 2007 Dec 1;25(34):5506-18
references: 17954710
references: Int J Radiat Oncol Biol Phys. 2000 Dec 1;48(5):1613-21
references: 11121668
references: Ann Oncol. 2006 Mar;17 Suppl 2:ii46-48
references: 16608981
references: Anticancer Drugs. 2008 Feb;19(2):99-113
references: 18176106
references: Int J Radiat Oncol Biol Phys. 2003 Mar 1;55(3):768-75
references: 12573764
references: Int J Gastrointest Cancer. 2001;30(3):123-32
references: 12540024
references: J Clin Oncol. 2008 May 10;26(14):2350-7
references: 18467727
references: Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):261-6
references: 11516876
references: Semin Radiat Oncol. 2002 Jan;12(1 Suppl 1):20-5
references: 11917280
references: Lancet. 1999 Jan 23;353(9149):267-72
references: 9929018
references: Clin Nucl Med. 2001 Feb;26(2):131-5
references: 11201470
references: Eur J Cancer. 2007 Jan;43(2):258-70
references: 17182241
references: Oncologist. 2008 May;13(5):477-93
references: 18515733
references: Drugs. 2008;68(7):901-12
references: 18457458
references: J Natl Cancer Inst. 2006 Sep 6;98(17):1183-92
references: 16954471
references: Lancet Oncol. 2006 Jul;7(7):584-95
references: 16814210
references: Int J Radiat Oncol Biol Phys. 1999 Oct 1;45(3):773-89
references: 10524434
references: Expert Opin Investig Drugs. 2008 Jun;17(6):865-78
references: 18491988
references: Radiother Oncol. 2002 Feb;62(2):163-71
references: 11937243
references: Radiother Oncol. 2001 Jul;60(1):81-9
references: 11410308
references: Lancet Oncol. 2007 Dec;8(12):1101-1115
references: 18054880
references: Nat Clin Pract Oncol. 2008 Jan;5(1):32-43
references: 18097455